Literature DB >> 35124194

Chemokines network in bone metastasis: Vital regulators of seeding and soiling.

Gunjan Sharma1, Ramesh Pothuraju1, Ranjana Kumari Kanchan1, Surinder Kumar Batra2, Jawed Akhtar Siddiqui3.   

Abstract

Chemokines are well equipped with chemo-attractive signals that can regulate cancer cell trafficking to specific organ sites. Currently, updated concepts have revealed the diverse role of chemokines in the biology of cancer initiation and progression. Genomic instabilities and alterations drive tumor heterogeneity, providing more options for the selection and metastatic progression to cancer cells. Tumor heterogeneity and acquired drug resistance are the main obstacles in managing cancer therapy and the primary root cause of metastasis. Studies emphasize that multiple chemokine/receptor axis are involved in cancer cell-mediated organ-specific distant metastasis. One of the persuasive mechanisms for heterogeneity and subsequent events is sturdily interlinked with the crosstalk between chemokines and their receptors on cancer cells and tissue-specific microenvironment. Among different metastatic niches, skeletal metastasis is frequently observed in the late stages of prostate, breast, and lung cancer and significantly reduces the survival of cancer patients. Therefore, it is crucial to elucidate the role of chemokines and their receptors in metastasis and bone remodeling. Here, we review the potential chemokine/receptor axis in tumorigenesis, tumor heterogeneity, metastasis, and vicious cycle in bone microenvironment.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Cancer; Chemokines; Drug resistance; Tumor heterogeneity

Year:  2022        PMID: 35124194     DOI: 10.1016/j.semcancer.2022.02.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   17.012


  1 in total

1.  Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis.

Authors:  Shuguang Li; Shuai Liu; Jianjun Xun; Feifei Zhao
Journal:  J Healthc Eng       Date:  2022-04-21       Impact factor: 3.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.